These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19042851)

  • 1. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.
    Haroutiunian S; Rosen G; Shouval R; Davidson E
    J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
    Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L
    Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
    Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
    J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.
    Schley M; Legler A; Skopp G; Schmelz M; Konrad C; Rukwied R
    Curr Med Res Opin; 2006 Jul; 22(7):1269-76. PubMed ID: 16834825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are oral cannabinoids safe and effective in refractory neuropathic pain?
    Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
    Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.
    de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H
    Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic use of cannabinoids: Forensic aspects.
    Indorato F; Liberto A; Ledda C; Romano G; Barbera N
    Forensic Sci Int; 2016 Aug; 265():200-3. PubMed ID: 27038587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tetrahydrocannabinol for treatment of chronic pain].
    Elsner F; Radbruch L; Sabatowski R
    Schmerz; 2001 Jun; 15(3):200-4. PubMed ID: 11810357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronabinol and chronic pain: importance of mechanistic considerations.
    de Vries M; van Rijckevorsel DC; Wilder-Smith OH; van Goor H
    Expert Opin Pharmacother; 2014 Aug; 15(11):1525-34. PubMed ID: 24819592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
    Svendsen KB; Jensen TS; Bach FW
    BMJ; 2004 Jul; 329(7460):253. PubMed ID: 15258006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
    Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
    Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.
    Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN
    J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
    Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
    Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.
    Walter C; Oertel BG; Ludyga D; Ultsch A; Hummel T; Lötsch J
    Br J Clin Pharmacol; 2014 Nov; 78(5):961-9. PubMed ID: 24802974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effect of delta-9-tetrahydrocannabinol.
    Noyes R; Brunk SF; Baram DA; Canter A
    J Clin Pharmacol; 1975; 15(2-3):139-43. PubMed ID: 1091664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronabinol use in France between 2004 and 2017.
    Lejczak S; Rousselot H; Di Patrizio P; Debouverie M
    Rev Neurol (Paris); 2019 May; 175(5):298-304. PubMed ID: 30948262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain relief with oral cannabinoids in familial Mediterranean fever.
    Holdcroft A; Smith M; Jacklin A; Hodgson H; Smith B; Newton M; Evans F
    Anaesthesia; 1997 May; 52(5):483-6. PubMed ID: 9165969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
    Wade DT; Robson P; House H; Makela P; Aram J
    Clin Rehabil; 2003 Feb; 17(1):21-9. PubMed ID: 12617376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.
    Buggy DJ; Toogood L; Maric S; Sharpe P; Lambert DG; Rowbotham DJ
    Pain; 2003 Nov; 106(1-2):169-72. PubMed ID: 14581124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.